PEX6
Peroxisomal ATPase PEX6
Also known as: PAF-2, PEX6_HUMAN, PXAAA1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13608
- Gene
- PEX6
- Ensembl
- ENSG00000124587
- Chromosome
- 6
- Canonical length
- 980 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) family of ATPases. This member is a predominantly cytoplasmic protein, which plays a direct role in peroxisomal protein import and is required for PTS1 (peroxisomal targeting signal 1, a C-terminal tripeptide of the sequence ser-lys-leu) receptor activity. Mutations in this gene cause peroxisome biogenesis disorders of complementation group 4 and complementation group 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Canonical amino-acid sequenceUniProt
980 residues, UniProt reviewed canonical sequence.
>Q13608|PEX6
1 MALAVLRVLE PFPTETPPLA VLLPPGGPWP AAELGLVLAL RPAGESPAGP ALLVAALEGP
61 DAGTEEQGPG PPQLLVSRAL LRLLALGSGA WVRARAVRRP PALGWALLGT SLGPGLGPRV
121 GPLLVRRGET LPVPGPRVLE TRPALQGLLG PGTRLAVTEL RGRARLCPES GDSSRPPPPP
181 VVSSFAVSGT VRRLQGVLGG TGDSLGVSRS CLRGLGLFQG EWVWVAQARE SSNTSQPHLA
241 RVQVLEPRWD LSDRLGPGSG PLGEPLADGL ALVPATLAFN LGCDPLEMGE LRIQRYLEGS
301 IAPEDKGSCS LLPGPPFARE LHIEIVSSPH YSTNGNYDGV LYRHFQIPRV VQEGDVLCVP
361 TIGQVEILEG SPEKLPRWRE MFFKVKKTVG EAPDGPASAY LADTTHTSLY MVGSTLSPVP
421 WLPSEESTLW SSLSPPGLEA LVSELCAVLK PRLQPGGALL TGTSSVLLRG PPGCGKTTVV
481 AAACSHLGLH LLKVPCSSLC AESSGAVETK LQAIFSRARR CRPAVLLLTA VDLLGRDRDG
541 LGEDARVMAV LRHLLLNEDP LNSCPPLMVV ATTSRAQDLP ADVQTAFPHE LEVPALSEGQ
601 RLSILRALTA HLPLGQEVNL AQLARRCAGF VVGDLYALLT HSSRAACTRI KNSGLAGGLT
661 EEDEGELCAA GFPLLAEDFG QALEQLQTAH SQAVGAPKIP SVSWHDVGGL QEVKKEILET
721 IQLPLEHPEL LSLGLRRSGL LLHGPPGTGK TLLAKAVATE CSLTFLSVKG PELINMYVGQ
781 SEENVREVFA RARAAAPCII FFDELDSLAP SRGRSGDSGG VMDRVVSQLL AELDGLHSTQ
841 DVFVIGATNR PDLLDPALLR PGRFDKLVFV GANEDRASQL RVLSAITRKF KLEPSVSLVN
901 VLDCCPPQLT GADLYSLCSD AMTAALKRRV HDLEEGLEPG SSALMLTMED LLQAAARLQP
961 SVSEQELLRY KRIQRKFAACLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PEX6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 72 nTPM
- cerebellum: 27 nTPM
- liver: 27 nTPM
- ovary: 25 nTPM
- pituitary gland: 24 nTPM
- choroid plexus: 23 nTPM
Single-cell type
- retinal bipolar cells: 67 nCPM
- respiratory ciliated cells: 58 nCPM
- fallopian tube ciliated cells: 52 nCPM
- retinal ganglion cells: 46 nCPM
- myonuclei: 46 nCPM
- leydig cells: 44 nCPM
Immune cell
- memory CD8 T-cell: 2.5 nTPM
- naive CD4 T-cell: 2.2 nTPM
- eosinophil: 2.1 nTPM
- MAIT T-cell: 2.1 nTPM
- naive CD8 T-cell: 2.1 nTPM
- NK-cell: 2 nTPM
Brain region
- medulla oblongata: 36 nTPM
- midbrain: 33 nTPM
- cerebral cortex: 32 nTPM
- hypothalamus: 32 nTPM
- choroid plexus: 32 nTPM
- basal ganglia: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PEX6.
Disease | AllUniProt
Conditions PEX6 is implicated in, by any mechanism.
- Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) MIM:614862
- Peroxisome biogenesis disorder 4A (PBD4A) MIM:614862
- Peroxisome biogenesis disorder 4B (PBD4B) MIM:614863
- Heimler syndrome 2 (HMLR2) MIM:616617
Disease | GeneticClinVar
303 pathogenic / likely-pathogenic of 1,971 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Peroxisome biogenesis disorder
- Heimler syndrome 2
- Peroxisome biogenesis disorder 4A (Zellweger)
- Peroxisome biogenesis disorder 4B
- Zellweger spectrum disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.44
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- peroxisome organization
- protein import into peroxisome matrix
- protein import into peroxisome matrix, receptor recycling
- protein import into peroxisome matrix, translocation
- protein stabilization
- protein targeting to peroxisome
- protein unfolding
Molecular functions
- ATP binding
- ATP hydrolysis activity
- protein transporter activity
- protein-containing complex binding
- ubiquitin-modified protein reader activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- AAA+ ATPase domain
- ATPase, AAA-type, core
- ATPase, AAA-type, conserved site
- P-loop containing nucleoside triphosphate hydrolase
- AAA ATPase domain-containing protein
- ATPase family associated with various cellular activities (AAA)
- Peroxisomal biogenesis factor 6, second ATPase domain
- Peroxisomal ATPase PEX6, double psi barrel domain
- Peroxisomal ATPase PEX6, N-terminal domain
- PEX6 N-terminal domain
- PEX6 double psi barrel domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PEX6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PEX6 as an antibody target. Whether an autoantibody or antibody against PEX6 could matter depends on whether native PEX6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PEX6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PEX6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...